LinkedIn post Isologic goes electric

šŸ”ŒIsologic Goes Electric!

We are excited to announce the expansion of our electric fleet with the addition of the Mercedes-Benz eCitan. This compact and sustainable vehicle boasts a range of approximately 280km and can be rapidly charged from 20% to 80% ursing fast-charging stations. 

Our commitment to electric mobility is driven by our collaboration with Radboud Translational Medicine B.V., where we transport medical isotopes daily to healthcare facilities both domestically and internationally. Furthermore, many of our clients are increasingly seeking sustainable logistics solutions. With the implementation of zero-emission zones in cities such as Nijmegen, and the expectation that more cities will follow this example, this is a significant step forward.

At Isologic, delivery reliability is paramount: it is crucial that hospitals receive the necessary medical sources on time for patient treatment. The Mercedes-Benz eCitan supports us in this mission with its dependable performance and swift charging capabilities.

A notable feature of this eCitan is its specialized software that optimizes temperature settings for efficient charging. We will now rigorously test the performance and reliability of this electric van, as we previously did with an electric FIAT Doblo. Interested in the results? Please contact us: https://lnkd.in/et8ny4EK

#Isologic hashtag#ElectricDriving hashtag#Sustainability hashtag#Logistics hashtag#Healthcare hashtag#ZeroEmission

LinkedIn post Isologic goes electric

Other news

1st production QuiremSpheres

1st production QuiremSpheres

On May 21st, the first patient dosis of QuiremSpheres was processed at RTM and then shipped to the s...

Read more

Production of novel diagnostic radionuclides in small medical cyclotrons

Production of novel diagnostic radionuclides in small medical cyclotrons

Employees from RTM and Radboudumc have published a new article: 'Production of novel diagnostic radi...

Read more

First liver cancer patient treated with microspheres irradiated in TU Delft

First liver cancer patient treated with microspheres irradiated in TU Delft

Radboud Translational Medicine will perform the dispensing of below product. The production and dis...

Read more

ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany

ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany

ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany! This marks the 8...

Read more

Interested in a collaboration?

Contact us to discuss the possibilities.